Supplementary Table S6 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
Year: 2026
Type: supplementary-materials
Abstract: Summary of the anti-tumor activity of TNG917 in the HT29 CDX huPBMC model
Authors: Alvin Ziying Lu, Brian B. Haines, Wenhai Zhang, Minjie Zhang, Douglas A. Whittington, Lei Ji, Teng Teng, Maria Dam Ferdinez, Yi Yu, Hongxiang Zhang, Lina Gu, Alice W. Tsai, Sirimas Sudsakorn, William D. Mallender, Brett D. Williams, Jon H. Come, Scott Throner, Joseph P. Vacca, Alan Huang, Chengyin Min, John P. Maxwell, Jannik N. Andersen, Ying-Nan P. Chen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7204994707